Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Weiyi PengPatrick Hwu

Abstract

OX40 agonist-based combinations are emerging as a novel avenue to improve the effectiveness of cancer immunotherapy. To better guide its clinical development, we characterized the role of the OX40 pathway in tumor-reactive immune cells. We also evaluated combining OX40 agonists with targeted therapy to combat resistance to cancer immunotherapy.Experimental Design: We utilized patient-derived tumor-infiltrating lymphocytes (TILs) and multiple preclinical models to determine the direct effect of anti-OX40 agonistic antibodies on tumor-reactive CD8+ T cells. We also evaluated the antitumor activity of an anti-OX40 antibody plus PI3Kβ inhibition in a transgenic murine melanoma model (Braf mutant, PTEN null), which spontaneously develops immunotherapy-resistant melanomas. We observed elevated expression of OX40 in tumor-reactive CD8+ TILs upon encountering tumors; activation of OX40 signaling enhanced their cytotoxic function. OX40 agonist antibody improved the antitumor activity of CD8+ T cells and the generation of tumor-specific T-cell memory in vivo. Furthermore, combining anti-OX40 with GSK2636771, a PI3Kβ-selective inhibitor, delayed tumor growth and extended the survival of mice with PTEN-null melanomas. This combination trea...Continue Reading

References

May 29, 1998·Journal of Molecular and Cellular Cardiology·B K Slinker
Nov 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lena SerghidesTania H Watts
Jul 3, 2008·Cancer Research·Michael J GoughAndrew D Weinberg
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brian A RabinovichPatrick Hwu
May 12, 2009·Immunological Reviews·Michael CroftPejman Soroosh
Oct 5, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Weiyi PengPatrick Hwu
Nov 16, 2010·Seminars in Oncology·Shawn M JensenBernard A Fox
Sep 10, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kui S VooYong J Liu
Nov 2, 2013·Cancer Research·Brendan D CurtiAndrew D Weinberg
Apr 17, 2014·Proceedings of the National Academy of Sciences of the United States of America·Fabienne SchmitJean J Zhao
Jun 7, 2014·Cancer Immunology Research·Zachary A CooperJennifer A Wargo
Apr 4, 2015·Science·Padmanee Sharma, James P Allison
Dec 10, 2015·Cancer Discovery·Weiyi PengPatrick Hwu
Dec 10, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sandrine AspeslaghAurélien Marabelle
Apr 2, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chester LaiEugene Healy
May 20, 2016·Clinical & Translational Immunology·Ryan MontlerAndrew Weinberg
Jun 25, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joaquin MateoHendrik-Tobias Arkenau
Jul 12, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jonathan SitrinTimothy W Behrens
Sep 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David J MessenheimerBernard A Fox
Jan 11, 2018·British Journal of Cancer·Russell W JenkinsKeith T Flaherty
Feb 2, 2018·Science Translational Medicine·Idit Sagiv-BarfiRonald Levy
Aug 24, 2018·Experimental & Molecular Medicine·Young-Jun ParkYeonseok Chung
Dec 14, 2018·Experimental & Molecular Medicine·Pramod DarvinEyad Elkord

❮ Previous
Next ❯

Citations

Dec 10, 2019·The Journal of Cell Biology·Kim Bich Nguyen, Stefani Spranger
Sep 10, 2020·Journal for Immunotherapy of Cancer·Lucia Campos CarrascosaJaap Kwekkeboom
Mar 12, 2020·Immune Network·Seongju Jeong, Su-Hyung Park
Jul 31, 2020·International Journal of Molecular Sciences·Fabiana ConciatoriMichele Milella
Oct 28, 2020·Cells·Daniel J TurnhamHelen B Pearson
Jan 23, 2021·Expert Review of Clinical Immunology·Azadehsadat RazaviNima Rezaei
Apr 21, 2021·BMC Cancer·Ziying LinYanbin Zhou
Jul 20, 2021·Frontiers in Cell and Developmental Biology·Daniele E MascarelliMarcio C Bajgelman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.